Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kinnate Biopharma Inc.

    NASDAQ: KNTE · Real-Time Price · USD
    2.65
    -0.01 (-0.38%)
    At close: Apr 02, 2024, 10:00 PM

    Kinnate Biopharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -112.65M -116.27M -89.76M
    Depreciation & Amortization
    		 799K 604K 123K
    Stock-Based Compensation
    		 19.92M 19.58M 15.02M
    Other Working Capital
    		 1.37M 2.17M -3.05M
    Other Non-Cash Items
    		 22.18M 682K 1.94M
    Deferred Income Tax
    		 -26.59M n/a n/a
    Change in Working Capital
    		 -3.7M 6.37M 1.62M
    Operating Cash Flow
    		 -100.04M -89.03M -71.06M
    Capital Expenditures
    		 n/a -2.72M -769K
    Cash Acquisitions
    		 -9.13M 4.11K 34.85M
    Purchase of Investments
    		 -154.72M -176.53M -247.14M
    Sales Maturities Of Investments
    		 264.59M 172.42M 67.34M
    Other Investing Acitivies
    		 n/a -4.11K -34.85M
    Investing Cash Flow
    		 100.74M -6.83M -180.57M
    Debt Repayment
    		 n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 -7.81M 1.16M 36.24M
    Financial Cash Flow
    		 1.32M 1.16K 36.24K
    Net Cash Flow
    		 2.01M -94.7M -215.4M
    Free Cash Flow
    		 -100.04M -91.75M -71.83M

    Add to Watchlist